191 related articles for article (PubMed ID: 19169894)
1. Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature.
Martiniova L; Lai EW; Elkahloun AG; Abu-Asab M; Wickremasinghe A; Solis DC; Perera SM; Huynh TT; Lubensky IA; Tischler AS; Kvetnansky R; Alesci S; Morris JC; Pacak K
Clin Exp Metastasis; 2009; 26(3):239-50. PubMed ID: 19169894
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells.
Ohta S; Lai EW; Morris JC; Pang AL; Watanabe M; Yazawa H; Zhang R; Green JE; Chan WY; Sirajuddin P; Taniguchi S; Powers JF; Tischler AS; Pacak K
Mol Carcinog; 2008 Apr; 47(4):245-51. PubMed ID: 17957724
[TBL] [Abstract][Full Text] [Related]
3. Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.
Martiniova L; Perera SM; Brouwers FM; Alesci S; Abu-Asab M; Marvelle AF; Kiesewetter DO; Thomasson D; Morris JC; Kvetnansky R; Tischler AS; Reynolds JC; Fojo AT; Pacak K
Endocr Relat Cancer; 2011 Feb; 18(1):143-57. PubMed ID: 21098082
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific metastatic phenotypes in pheochromocytoma allograft mice.
Ullrich M; Liers J; Peitzsch M; Feldmann A; Bergmann R; Sommer U; Richter S; Bornstein SR; Bachmann M; Eisenhofer G; Ziegler CG; Pietzsch J
Endocr Relat Cancer; 2018 Oct; 25(12):993-1004. PubMed ID: 30288966
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.
Martiniova L; Kotys MS; Thomasson D; Schimel D; Lai EW; Bernardo M; Merino MJ; Powers JF; Ruzicka J; Kvetnansky R; Choyke PL; Pacak K
J Magn Reson Imaging; 2009 Mar; 29(3):685-91. PubMed ID: 19243052
[TBL] [Abstract][Full Text] [Related]
6. In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma.
Ullrich M; Bergmann R; Peitzsch M; Cartellieri M; Qin N; Ehrhart-Bornstein M; Block NL; Schally AV; Pietzsch J; Eisenhofer G; Bornstein SR; Ziegler CG
Endocrinology; 2014 Nov; 155(11):4149-56. PubMed ID: 25137029
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.
Lai EW; Joshi BH; Martiniova L; Dogra R; Fujisawa T; Leland P; de Krijger RR; Lubensky IA; Elkahloun AG; Morris JC; Puri RK; Pacak K
J Clin Endocrinol Metab; 2009 Aug; 94(8):2952-7. PubMed ID: 19491224
[TBL] [Abstract][Full Text] [Related]
8. Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?
Korpershoek E; Pacak K; Martiniova L
Endocr Pathol; 2012 Mar; 23(1):43-54. PubMed ID: 22323007
[TBL] [Abstract][Full Text] [Related]
9. Animal models of pheochromocytoma.
Tischler AS; Powers JF; Alroy J
Histol Histopathol; 2004 Jul; 19(3):883-95. PubMed ID: 15168351
[TBL] [Abstract][Full Text] [Related]
10. Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.
Martiniova L; Lai EW; Thomasson D; Kiesewetter DO; Seidel J; Merino MJ; Kvetnansky R; Pacak K
Endocr Regul; 2009 Apr; 43(2):59-64. PubMed ID: 19856710
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
[TBL] [Abstract][Full Text] [Related]
12. Survivin: a novel neuroendocrine marker for pheochromocytoma.
Koch CA; Vortmeyer AO; Diallo R; Poremba C; Giordano TJ; Sanders D; Bornstein SR; Chrousos GP; Pacak K
Eur J Endocrinol; 2002 Mar; 146(3):381-8. PubMed ID: 11888845
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy.
Thouënnon E; Elkahloun AG; Guillemot J; Gimenez-Roqueplo AP; Bertherat J; Pierre A; Ghzili H; Grumolato L; Muresan M; Klein M; Lefebvre H; Ouafik L; Vaudry H; Plouin PF; Yon L; Anouar Y
J Clin Endocrinol Metab; 2007 Dec; 92(12):4865-72. PubMed ID: 17878247
[TBL] [Abstract][Full Text] [Related]
14. First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells.
Pfragner R; Behmel A; Smith DP; Ponder BA; Wirnsberger G; Rinner I; Porta S; Henn T; Niederle B
J Neurocytol; 1998 Mar; 27(3):175-86. PubMed ID: 10640177
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma.
Giubellino A; Shankavaram U; Bullova P; Schovanek J; Zhang Y; Shen M; Patel N; Elkahloun A; Lee MJ; Trepel J; Ferrer M; Pacak K
PLoS One; 2014; 9(4):e90458. PubMed ID: 24699253
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
19. Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging.
Giubellino A; Woldemichael GM; Sourbier C; Lizak MJ; Powers JF; Tischler AS; Pacak K
Cancer Lett; 2012 Mar; 316(1):46-52. PubMed ID: 22154086
[TBL] [Abstract][Full Text] [Related]
20. Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.
Nölting S; Giubellino A; Tayem Y; Young K; Lauseker M; Bullova P; Schovanek J; Anver M; Fliedner S; Korbonits M; Göke B; Vlotides G; Grossman A; Pacak K
Endocrinology; 2014 Jul; 155(7):2377-90. PubMed ID: 24762141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
